Dendreon Corp (NASDAQ:DNDN)
| CAPS Rating |
|
|---|---|
| Open | $14.46 |
| Previous Close | $14.78 |
| Daily Range | $13.81 - $14.55 |
| 52-Week Range | $6.46 - $43.96 |
| Market Cap | $2.09B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 10,412,487 |
| Average Daily Volume | 0 |
DNDN
VS S&P 500 (SPY)
How do you think DNDN will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
DNDN Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
DNDN News and Commentary
- Buzz on the Street: Hurtling Through Chaos – Minyanville
- When Passing Your Clinical Trial Isn't Enough – The Motley Fool
- This Just In: More Upgrades and Downgrades – The Motley Fool
- Is Avanir Pharmaceuticals the Perfect Stock? – The Motley Fool
- Can Amgen Convince Docs to Recommend Approval? – The Motley Fool
- Minyanville's T3 Daily Recap: Market Quiet, but Stocks Moving -- What Does It Mean for the Rally? – Minyanville
- What's Going on With These Biotech Stocks? – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Dendreon Gets a New CEO - Analyst Blog – NASDAQ
- Whoa! What Just Happened to My Stock? – The Motley Fool
- New CEO = Dendreon Takeover Target? – The Motley Fool
- Side Effect of Low Side Effects: 20% Stock Gain – The Motley Fool
- UPDATE: Dendreon Names New CEO To Spur Sales Growth For Provenge – SmartMoney
- Medivation Prostate Cancer Drug Works Well, Appears Safe in Study – Minyanville
- Dendreon Picks Savient CEO Johnson To Succeed Gold At Helm – SmartMoney
- This Drug Approval Is Good For the Industry – The Motley Fool
- This Just In: More Upgrades and Downgrades – The Motley Fool
- The Simple Strategy That Beat the Market – The Motley Fool
- 3 Stocks Our Analysts Are Buying Right Now – The Motley Fool
- Has Sequenom Become the Perfect Stock? – The Motley Fool
RSS Headlines
Fool UK
